Lactoferrin versus iron polymaltose for the treatment of iron deficiency anemia in Egyptian children with cerebral palsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201911857573624

Enrollment

Registered

2019-11-19

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders Neonatal Diseases Nutritional, Metabolic, Endocrine

Interventions

Lactoferrin

Iron polymaltose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with a formal diagnosis of cerebral palsy by a specialist in the management of children with cerebral palsy. children with cerebral palsy diagnosed with iron deficiency anemia.

Exclusion criteria

Exclusion criteria: Children who have received oral iron preparations over the previous 6 months. Children having a medical or family history of beta thalassaemia or haemoglobinopathies. Children who are currently suffering from an acquired acute infectious illness.

Design outcomes

Primary

Measure	Time frame
Hemoglobin level;Serum ferritin	—

Secondary

Measure	Time frame
Constipation	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026